James Collins - Curriculum Vitae#

• PhD, Medical Engineering, University of Oxford, Oxford, England, 1990
  
• AB, Physics (Summa Cum Laude), College of the Holy Cross, Worcester, MA, USA, 1987

• 2024 - present Visiting Professor of Engineering Science, University of Oxford
  
• 2014 - present Termeer Professor of Medical Engineering & Science, MIT
  
• 2014 - present Professor, Department of Biological Engineering, MIT
  
• 2014 - present Institute Member, Broad Institute of MIT and Harvard
  
• 2008 - present Core Founding Faculty Member, Wyss Institute, Harvard University

• Taught over 2500 bioengineering undergraduates in the classroom.
  
• Mentored over 200 undergraduates, graduate students and postdocs in the lab. Trainees have become faculty members at leading universities and institutes, such as Imperial College London, Karolinska Institute, University of Gothenburg, University of Naples, Leiden University,
  

• Over 900 invited talks at national and international conferences, academic institutions and research organizations, including Keynote Lectures at Synthetic Biology 1.0 and the Nobel Conference on Biofilm Formation.
  

• Member of the editorial board of several journals, including Science, Cell, and PNAS.
  

• Scientific co-founder: Senti Biosciences, Sherlock Biosciences, Cellarity; board member: Fulcrum Therapeutics, Sherlock Biosciences, Senti Biosciences, Cellarity; Scientific Advisory Board member: Danaher, Shape Therapeutics, Radar Therapeutics, Integrated Therapeutics, Florey Biosciences, Express Therapeutics, Montai Health, Typewriter Therapeutics, Engine Biosciences, Invaio Sciences, Phare Bio, Catalio Capital Management, and MA Governor’s Life Sciences Board.
  
• Invited chair or organizer for more than 25 national and international scientific meetings, including the First SIAM Conference on the Life Sciences and the International Conference on Synthetic Biology.